During this fireside chat we welcome Delcath Systems CEO Gerard Michel. Delcath is an interventional oncology company focused on the treatment of primary and metastatic liver cancers.

This Fireside Chat was recorded during the Lytham Partners Fall 2023 Investor Conference.